Laura Moise
Overview
Explore the profile of Laura Moise including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naffrichoux J, Poupin P, Pouillot W, Linassier C, Rioux-Leclercq N, De Vries-Brilland M, et al.
Eur J Cancer
. 2024 May;
205:114121.
PMID: 38749111
Introduction: Papillary renal cell carcinoma (pRCC) is a rare and aggressive cancer with no specifically established therapeutic strategy in the metastatic setting. Combinations of tyrosine kinase and immune checkpoint inhibitors...
2.
Cancel M, Fromont G, Blonz C, Chevreau C, Rioux-Leclercq N, Laguerre B, et al.
Eur J Cancer
. 2021 Oct;
158:1-11.
PMID: 34619467
Background: Two phase II trials (NCT00688753 and NCT00541008) reported efficacy data of sunitinib and everolimus in first-line treatment of metastatic papillary renal cell carcinoma (mpRCC). Although most patients receive sunitinib...
3.
Voog E, Campillo-Gimenez B, Elkouri C, Priou F, Rolland F, Laguerre B, et al.
Int J Cancer
. 2019 Jul;
146(6):1643-1651.
PMID: 31318983
The treatment landscape in metastatic renal cell carcinoma has changed fundamentally over the last decade by the development of antiangiogenic agents, mammalian target of rapamycin inhibitors and immunotherapy. Outside of...
4.
Rascu A, Naghi E, Moise L, Otelea M
Pneumologia
. 2018 Mar;
65(4):212-5.
PMID: 29542906
Obstructive sleep apnea syndrome (OSAS) is a health issue of major importance globally. Although OSAS has a prevalence of 4-10% in the general population, it is less diagnosed, with redoubtable...
5.
Johnson A, Dugue A, Silva M, Moise L, Tillou X, Joly F, et al.
EJNMMI Res
. 2016 Nov;
6(1):84.
PMID: 27873241
Background: The objective of this study is to explore the impact of PSA nadirs on detection rates of prostate cancer (PCa) recurrence with F-choline (CH) PET/CT after external beam radiation...
6.
Rascu A, Moise L, Naghi E, Handra C, Otelea M, Rascu A, et al.
Rom J Intern Med
. 2015 Jun;
53(1):89-94.
PMID: 26076566
Sleep Apnea Syndrome (SAS) constitutes a healthcare issue of major importance at international level with a prevalence of 5% in the active population. Consequentially to the induced co-morbidities, the mortality...
7.
Houede N, Beuzeboc P, Gourgou S, Tosi D, Moise L, Gravis G, et al.
BMC Cancer
. 2015 Apr;
15:222.
PMID: 25884302
Background: COU-AA-301 trial has proved that abiraterone acetate (AA), a selective inhibitor of androgen biosynthesis, improved overall survival (OS) of patients with metastatic castration resistant prostate cancer (mCRPC) after a...
8.
Moise L, Matta C, Hanna C, Pilorge S, Ferme C, Durrbach A, et al.
Leuk Lymphoma
. 2010 Dec;
52(3):521-4.
PMID: 21133726
No abstract available.